The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

August 6, 2018

Study Completion Date

August 17, 2018

Conditions
Obesity
Interventions
DRUG

Leu Sil 1.0mg

Leu 1100 mg + 1mg Sil BID

DRUG

Leu Sil 4.0mg

Leu 1100 mg + 4mg Sil BID

DRUG

Leu Met Sil 1.0mg

Leu 1100 mg + Met 500mg + 1mg Sil BID

DRUG

Leu Met Sil 4.0mg

Leu 1100 mg + Met 500mg + 4mg Sil BID

DRUG

Placebo

Placebo

Trial Locations (15)

29407

Medical Research South, Charleston

36608

AMR, Mobile

37040

Premier, Clarksville

44122

Rapid Medical Research, Cleveland

60602

Synexus, Chicago

63141

Synexus, St Louis

70006

Clinical Trials Management, Metairie

70808

Pennington Biomedical Research Center, Baton Rouge

75234

Synexus, Dallas

78229

Synexus, San Antonio

83642

ACR, Meridian

84088

ACR, Jordan

89119

AMR, Las Vegas

91763

Catalina Research Institute, Montclair

95821

Northern California Research, Sacramento

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NuSirt Biopharma

INDUSTRY